These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 23297842)

  • 21. Solventless granulation and spheronization of indomethacin crystals using a mechanical powder processor: Effects of mechanically induced amorphization on particle formation.
    Kondo K; Miyamoto K; Miura S; Niwa T
    Eur J Pharm Biopharm; 2020 Sep; 154():348-358. PubMed ID: 32755618
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insights on the Physical State Reached by an Active Pharmaceutical Ingredient upon High-Energy Milling.
    Schammé B; Monnier X; Couvrat N; Delbreilh L; Dupray V; Dargent É; Coquerel G
    J Phys Chem B; 2017 May; 121(19):5142-5150. PubMed ID: 28430440
    [TBL] [Abstract][Full Text] [Related]  

  • 23. X-ray powder diffractometry in combination with principal component analysis--a tool for monitoring solid state changes.
    Kogermann K; Veski P; Rantanen J; Naelapää K
    Eur J Pharm Sci; 2011 Jul; 43(4):278-89. PubMed ID: 21575718
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Crystalline Polymorphism Emerging From a Milling-Induced Amorphous Form: The Case of Chlorhexidine Dihydrochloride.
    Elisei E; Willart JF; Danède F; Siepmann J; Siepmann F; Descamps M
    J Pharm Sci; 2018 Jan; 107(1):121-126. PubMed ID: 28716502
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spontaneous crystalline-to-amorphous phase transformation of organic or medicinal compounds in the presence of porous media, part 1: thermodynamics of spontaneous amorphization.
    Qian KK; Bogner RH
    J Pharm Sci; 2011 Jul; 100(7):2801-15. PubMed ID: 21337545
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of microcrystalline cellulose based comilled powder on the compression and dissolution of ibuprofen.
    Mallick S; Pradhan SK; Mohapatra R
    Int J Biol Macromol; 2013 Sep; 60():148-55. PubMed ID: 23732329
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of milling conditions on the solid-state conversion of ranitidine hydrochloride form 1.
    Chieng N; Zujovic Z; Bowmaker G; Rades T; Saville D
    Int J Pharm; 2006 Dec; 327(1-2):36-44. PubMed ID: 16949221
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improvement in solubility and bioavailability of puerarin by mechanochemical preparation.
    Xie J; Yang F; Shi X; Zhu X; Su W; Wang P
    Drug Dev Ind Pharm; 2013 Jun; 39(6):826-35. PubMed ID: 22591175
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of excipients in comilling on mitigating milling-induced amorphization or structural disorder of crystalline pharmaceutical actives.
    Balani PN; Ng WK; Tan RB; Chan SY
    J Pharm Sci; 2010 May; 99(5):2462-74. PubMed ID: 19902526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Formation of physically stable amorphous drugs by milling with Neusilin.
    Gupta MK; Vanwert A; Bogner RH
    J Pharm Sci; 2003 Mar; 92(3):536-51. PubMed ID: 12587115
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Physical characterization and stability of amorphous indomethacin and ranitidine hydrochloride binary systems prepared by mechanical activation.
    Chieng N; Aaltonen J; Saville D; Rades T
    Eur J Pharm Biopharm; 2009 Jan; 71(1):47-54. PubMed ID: 18644443
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thermal insight of mechanically activated bile acid powders.
    Ito T; Byrn S; Chen X; Carvajal MT
    Int J Pharm; 2011 Nov; 420(1):68-75. PubMed ID: 21872650
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantifying Dry Milling in Pharmaceutical Processing: A Review on Experimental and Modeling Approaches.
    Naik S; Chaudhuri B
    J Pharm Sci; 2015 Aug; 104(8):2401-13. PubMed ID: 26096636
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of crystal morphology and mill type on milling induced crystal disorder.
    Chikhalia V; Forbes RT; Storey RA; Ticehurst M
    Eur J Pharm Sci; 2006 Jan; 27(1):19-26. PubMed ID: 16246535
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of powder processing on performance of fenofibrate formulations.
    Jain RA; Brito L; Straub JA; Tessier T; Bernstein H
    Eur J Pharm Biopharm; 2008 Jun; 69(2):727-34. PubMed ID: 18226885
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determination of amorphous content in the pharmaceutical process environment.
    Savolainen M; Jouppila K; Pajamo O; Christiansen L; Strachan C; Karjalainen M; Rantanen J
    J Pharm Pharmacol; 2007 Feb; 59(2):161-70. PubMed ID: 17270070
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Solid state mutarotation of glucose.
    Dujardin N; Dudognon E; Willart JF; Hédoux A; Guinet Y; Paccou L; Descamps M
    J Phys Chem B; 2011 Feb; 115(7):1698-705. PubMed ID: 21271722
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amorphization of itraconazole by inorganic pharmaceutical excipients: comparison of excipients and processing methods.
    Grobelny P; Kazakevich I; Zhang D; Bogner R
    Pharm Dev Technol; 2015 Jan; 20(1):118-27. PubMed ID: 25312240
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An example of how to handle amorphous fractions in API during early pharmaceutical development: SAR114137--a successful approach.
    Petzoldt C; Bley O; Byard SJ; Andert D; Baumgartner B; Nagel N; Tappertzhofen C; Feth MP
    Eur J Pharm Biopharm; 2014 Apr; 86(3):337-50. PubMed ID: 24075979
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Formation of physically stable amorphous phase of ibuprofen by solid state milling with kaolin.
    Mallick S; Pattnaik S; Swain K; De PK; Saha A; Ghoshal G; Mondal A
    Eur J Pharm Biopharm; 2008 Feb; 68(2):346-51. PubMed ID: 17669640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.